NCT06729710

Brief Summary

This study is a prospective randomized study aiming to investigate the effect of prism adaptation before surgery for symptomatic esophoria on the number of reoperations, the occurrence of over- and under-correction after the first surgery, and symptom resolution. Additionally, we aim to define the optimal duration of prism adaptation.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
44mo left

Started May 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress21%
May 2025Jan 2030

First Submitted

Initial submission to the registry

December 4, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 11, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

May 19, 2025

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2028

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2030

Last Updated

July 22, 2025

Status Verified

July 1, 2025

Enrollment Period

2.6 years

First QC Date

December 4, 2024

Last Update Submit

July 21, 2025

Conditions

Keywords

Esophoriaprism adaptationstrabismus surgery

Outcome Measures

Primary Outcomes (2)

  • Reoperation rate

    Number of patients in need of reoperation after initial surgery for symptomatic esophoria

    Up to 5 years

  • Measured deviation angle at the conclusion of prism adaptation.

    Measured deviation angle in prism diopters at the conclusion of prism adaptation.

    Up to 5 years

Secondary Outcomes (3)

  • Motor success

    1 year from date of surgery

  • Sensory success

    1 year from date of surgery

  • Symptomatic success

    1 year from date of surgery

Study Arms (2)

1 hour prism adaptation

ACTIVE COMPARATOR

Patients who receive one hour of prism adaptation.

Procedure: Prism adaptation testProcedure: other

4 hours of prism adaptation

ACTIVE COMPARATOR

Patients who receive four hour of prism adaptation.

Procedure: Prism adaptation testProcedure: other

Interventions

Prism Adapation test for 1 hour in one group, and 4 hours in second group

1 hour prism adaptation4 hours of prism adaptation
otherPROCEDURE

Surgery based on prism adaptation test of 1 hour in one group and 4 hours in second group

Also known as: Surgery based on prism adaptation test
1 hour prism adaptation4 hours of prism adaptation

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with symptomatic esophoria who meet one or more of the following criteria:
  • Double vision
  • Asthenopia (eye strain)
  • Headaches related to esophoria
  • Worsening of symptoms during fatigue, sleep deprivation, reading, illness, or alcohol consumption.

You may not qualify if:

  • Accommodative esotropia or esophoria
  • Myopia exceeding 10 diopters in the most myopic meridian
  • Inability to undergo reliable orthoptic measurements or prism adaptation
  • Previous strabismus surgery
  • Myogenic disorders (including Myasthenia Gravis)
  • Restrictive strabismus (including previous eye muscle trauma or Graves' orbitopathy)
  • Eye muscle paresis
  • Maximum prism-adapted deviation angle \>40 prism diopters (PD) in any gaze direction for distance
  • Maximum prism-adapted deviation angle with ≥20 PD difference between near and distance measurements

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rigshospitalet

Copenhagen, 2600, Denmark

RECRUITING

MeSH Terms

Conditions

Esotropia

Condition Hierarchy (Ancestors)

StrabismusOcular Motility DisordersCranial Nerve DiseasesNervous System DiseasesEye Diseases

Central Study Contacts

Mikael Hofsli, M.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

December 4, 2024

First Posted

December 11, 2024

Study Start

May 19, 2025

Primary Completion (Estimated)

January 1, 2028

Study Completion (Estimated)

January 1, 2030

Last Updated

July 22, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations